Recent advances in arthritis management have significantly improved patient outcomes and quality of life. Clinicians should be aware of emerging biologic therapies and targeted synthetic disease-modifying antirheumatic drugs (DMARDs), which offer more personalized treatment options for both rheumatoid and psoriatic arthritis. Innovations in imaging techniques and biomarker identification are enhancing early diagnosis and disease monitoring.
Additionally, multidisciplinary approaches incorporating physical therapy, lifestyle modifications, and patient education are proving essential in comprehensive care. Staying updated on these developments is crucial for optimizing long-term joint health and minimizing disease progression. In observance of Arthritis Awareness Month , we are pleased to present an informative webinar on the latest in arthritis management, in collaboration with the Bone…
